Business Wire

Duravant to Acquire Pattyn, Provider of Packaging Automation Systems for Bulk and Industrial Applications

7.2.2025 15:00:00 CET | Business Wire | Press release

Share

Automation solutions leader Duravant has signed a definitive agreement to acquire Pattyn.

Duravant LLC (“Duravant”), a global engineered equipment and automation solutions provider to the food processing, packaging and material handling sectors, announced today that it has entered into a definitive agreement to acquire the Pattyn Group BV (‘Pattyn”), a designer and manufacturer of automation systems specializing in B2B packaging. Pattyn is recognized as the premier leader for delivering comprehensive automation solutions and value-added services for bag-in-box packaging applications. Headquartered in Bruges, Belgium, Pattyn has over 70 years of expertise in machinery design and turnkey systems for counting, weighing, filling, and packing technologies for food, ingredients, and various non-food sectors.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250207117623/en/

“We are extremely excited to partner with Pattyn,” said Mike Kachmer, Chairman and CEO of Duravant. “Pattyn has a rich history delivering high quality solutions to a global customer base in over 80 countries. Their impressive growth is attributed to their unwavering focus on customer satisfaction and building lasting relationships, which aligns perfectly with Duravant’s dedication to ensuring customer success.”

Pattyn operates out of six specialized manufacturing sites in Belgium, France and Spain and has sales and service divisions in North America and Asia. Founded by Jean Pattyn in 1952 and expanded through the vision of Paul Pattyn in 1976, the company grew from a local business to a worldwide supplier of packaging automation. Pattyn’s third generation owners and shareholders Stan Pattyn and Lynn Pattyn, alongside Pattyn COO Benjamin de Chilly, further led the company’s transformation with continuous innovation and development of new packaging technologies, digital offerings, and a service-minded approach from design to installation and complete aftermarket support.

“Pattyn has had a strong track record of solid performance, and we know that our potential to grow faster will happen alongside a strong partner,” said Stan Pattyn. “Through further investments in product development, operational excellence, and emerging market expansion, we will not only continue to thrive, but we will be empowered to better serve our customers and partners around the globe. Duravant is the perfect partner for the Pattyn Group and our employees.”

“We are thrilled to join forces with Duravant and collaborate with their family of world-class brands,” said Lynn Pattyn. “Duravant has a leading position across a wide array of end markets, from food & beverage to consumer goods, agriculture and industrial goods, to logistics and e-commerce. Pattyn’s opportunity to expand into new end markets with Duravant is core to our growth vision. But what’s most exciting is that Duravant’s customer-centric culture aligns perfectly with Pattyn’s commitment to delivering an excellent customer experience. We share that same DNA.”

Benjamin de Chilly adds, “Duravant is a true global organization with deep roots in Europe. They have a strong manufacturing footprint on the continent with renowned automation equipment brands such as Mespack, Votech, Marelec, Foodmate, Henneken, Multiscan, FMH Conveyors and Motion06. They recently invested in emerging markets Brazil, Mexico, China and Thailand where they established local sales, parts and service infrastructure to enhance their ability to serve customers in those regions.”

Pattyn represents a strategic acquisition for Duravant, expanding the company’s packaging machinery portfolio with innovative engineered solutions. Pattyn’s advanced automation technologies provide custom solutions through modular system designs while their equipment and consumables meet the highest food safety standards. Pattyn’s strong solution set for bakery applications further deepens Duravant’s relationships with customers in this sector.

The transaction, which remains subject to customary regulatory approvals, is expected to close in the second quarter of 2025. Following the close of the transaction, Pattyn will be a distinct Operating Company within Duravant’s Packaging Solutions Group. The current Pattyn Group management team will continue to oversee operations after the completion of the sale, and Pattyn’s 550 employees will join Duravant’s 3600 employees around the globe.

About Duravant

Headquartered in Downers Grove, IL, Duravant is a global engineered equipment company with manufacturing, sales and service facilities throughout North America, South America, Europe and Asia. Through their portfolio of operating companies, Duravant delivers trusted end-to-end automation solutions for customers and partners through engineering and integration expertise, project management and operational excellence. With worldwide sales distribution and support through the Duravant Lifecycle Services network, they provide immediate and lifetime aftermarket support to all the markets they serve in the protein processing, food sorting and handling, packaging, and material handling sectors. Duravant’s market-leading brands are synonymous with innovation, durability and reliability. For more information, visit www.duravant.com.

About Pattyn

Headquartered in Bruges, Belgium, Pattyn Group is a manufacturer and service provider of innovative and highly engineered packaging automation equipment specializing in modular solutions for counting, weighing, filling and bag-in-a-box applications. Since 1952, the company serves the B2B packaging segment and a diverse customer base that includes food and non-food producers in over 80 countries worldwide. Committed to fostering lifetime partnerships, Pattyn designs and delivers turnkey packaging lines with innovative modular designs that deliver custom solutions. The company provides aftermarket support with consumables, parts and comprehensive service programs. With 6 manufacturing sites in Belgium, France and Spain, and sales and service hubs in the United States and Asia, Pattyn partners with their customers to improve the efficiency, performance and quality of their industrial packaging needs. For more information, visit www.pattyn.com

View source version on businesswire.com: https://www.businesswire.com/news/home/20250207117623/en/

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Barilla Opens Global Call for Startups Through Good Food Makers 202625.5.2026 11:47:00 CEST | Press release

The program has involved over 1,100 startups across 50+ countries, delivering 26 pilot projects. Barilla Group has opened applications for the 2026 edition of Good Food Makers, its global open innovation program designed to co-develop and test new innovative solutions with startups and innovators inside real industrial environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521973445/en/ Since its launch in 2019, the program has involved more than 1,100 startups from over 50 countries, leading to 26 pilot projects, with over 20 projects currently active thanks to the solutions developed by the program’s alumni. This highlights the program’s role as a concrete platform for industrial scalable innovation. The 2026 edition comes at a pivotal moment for the company, following the launch of BITE (Barilla Innovation & Technology Experience), the new innovation center dedicated to developing the next generation of food prod

JEOL: Sales Launch of the Laser SEM System “LazEdge”25.5.2026 10:16:00 CEST | Press release

JEOL Ltd. (President & CEO: Izumi Oi) has developed the “LazEdge”, an SEM system equipped with a laser processing system, and begins sales on May 25, 2026. Cross-section preparation instruments such as the focused ion beam system (FIB system), are widely used in science and technology fields across research institutes, universities, and industries. In recent years, demand is increasing for a system that can process large-areas at a high speed, while achieving high-quality of the processed surface. “LazEdge” is an instrument integrating JEOL’s SEM with the laser technology proprietary of Hamamatsu Photonics K.K., and enables laser processing inside the specimen chamber of the electron microscope. This system enables high-quality cross-section specimens produced through high-speed, large-area processing to be transferred seamlessly to subsequent analyses, such as SEM observation, elemental analysis, and crystal orientation analysis, without exposure to the external environment. As a resu

TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 08:00:00 CEST | Press release

TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it

Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release

A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us

Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release

Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye